Beyond the Code: How DNA Nanotechnology is Moving from Molecular Origami to Programmable Biotech Platforms

Biotech treats DNA primarily as a coding material that provides information about disease phenotypes and can serve as a drug target and modality. But beyond the code, DNA is also an attractive programmable nanomaterial. By exploiting the predictability of Watson–Crick base pairing, researchers can create self-assembled DNA nanostructures with nanometer-scale precision.